thiazolidines has been researched along with Renal Insufficiency in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emoto, C; Nakamaru, Y; Shimizu, M; Yamazaki, H | 1 |
| Dingemanse, J; Guérard, N; Hoch, M; Zwingelstein, C | 1 |
| Biffi, M; Coppi, G; Mailland, F; Silingardi, S; Spotti, D | 1 |
3 trial(s) available for thiazolidines and Renal Insufficiency
| Article | Year |
|---|---|
Human pharmacokinetic profiling of the dipeptidyl peptidase-IV inhibitor teneligliptin using physiologically based pharmacokinetic modeling.
Topics: Adult; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Female; Humans; Intestinal Mucosa; Ketoconazole; Liver; Liver Diseases; Male; Middle Aged; Models, Biological; Pyrazoles; Renal Insufficiency; Reproducibility of Results; Thiazolidines; Young Adult | 2015 |
Effect of Hepatic or Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Ponesimod, a Selective S1P1 Receptor Modulator.
Topics: Adult; Area Under Curve; Case-Control Studies; Female; Humans; Liver Diseases; Male; Middle Aged; Receptors, Lysosphingolipid; Renal Insufficiency; Severity of Illness Index; Thiazoles; Thiazolidines | 2016 |
Pharmacokinetics of pidotimod in elderly volunteers and in renal failure patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Female; Half-Life; Humans; Immunologic Factors; Injections, Intravenous; Intestinal Absorption; Male; Middle Aged; Pyrrolidonecarboxylic Acid; Renal Insufficiency; Thiazoles; Thiazolidines; Urea | 1994 |